NCT03075488

Brief Summary

The study is aimed at evaluating whether ultrasound pre-procedural scan with Accuro may reduce needle redirections when performing spinal injection in patients with BMI = or \> 30 in orthopedic surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 9, 2017

Completed
22 days until next milestone

Study Start

First participant enrolled

March 31, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2018

Completed
Last Updated

February 1, 2019

Status Verified

July 1, 2018

Enrollment Period

1 year

First QC Date

March 6, 2017

Last Update Submit

January 30, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Needle redirections

    To evaluate if there is a significant difference about numbers of needle redirections between conventional landmark guided technique and Accuro device guided technique

    duration of spinal injection procedure

Secondary Outcomes (5)

  • Number of needle insertions

    duration of spinal injection procedure

  • Procedure duration

    duration of spinal injection procedure

  • Side effects and complications

    36 months

  • Procedure failure

    duration of surgical procedure

  • Patient satisfaction

    24 hours

Study Arms (2)

Conventional landmark-guided technique

ACTIVE COMPARATOR

In this arm spinal anesthesia will be performed by using conventional cutaneous landmarks

Procedure: cutaneous landmarks

Accuro device guided technique

EXPERIMENTAL

In this arm spinal anesthesia will be performed only after having detected the intralaminar space, the mid-line, the depth and the orientation for spinal needle insertion with pre-procedural scan performed with Accuro device

Device: Accuro

Interventions

AccuroDEVICE

spinal anesthesia injection based on identification of entry site with pre-procedural ultrasound scan with Accuro device

Accuro device guided technique

spinal anesthesia injection based on identification of entry site with palpation of cutaneous landmarks

Conventional landmark-guided technique

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 75 years
  • BMI ≥ 30 kg/m2
  • American Society of Anesthesiologists' (ASA) classification I-III
  • Orthopedic surgery to be performed under spinal anesthesia
  • Able to understand and to sign informed consent

You may not qualify if:

  • Local anaesthetic allergy
  • Serious spine deformities
  • Previous spine surgery
  • Inability to express informed consent
  • Contraindications to spinal anaesthesia
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Ortopedico Rizzoli

Bologna, 40136, Italy

Location

Related Publications (1)

  • Ghisi D, Tomasi M, Giannone S, Luppi A, Aurini L, Toccaceli L, Benazzo A, Bonarelli S. A randomized comparison between Accuro and palpation-guided spinal anesthesia for obese patients undergoing orthopedic surgery. Reg Anesth Pain Med. 2019 Oct 25:rapm-2019-100538. doi: 10.1136/rapm-2019-100538. Online ahead of print.

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

March 6, 2017

First Posted

March 9, 2017

Study Start

March 31, 2017

Primary Completion

April 3, 2018

Study Completion

April 3, 2018

Last Updated

February 1, 2019

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations